Recent work by the Buckwalter Lab at Stanford University indicates that eliminating B cells following stroke may protect patients from later developing vascular dementia.
Translational medicine is a field aimed at combining disciplines, resources, expertise, and techniques to improve the way we prevent, diagnose, and treat diseases. It starts with basic laboratory research, where scientists study the mechanisms by which diseases make us sick and identify ways that we can intervene and prevent illness. From these findings, new methods of prevention, diagnosis, and treatment are developed and tested in a clinical setting. Once they are validated as safe and effective in clinical trials, new treatments are introduced to the public. Because of the complex nature of disease, collaborations between scientists of diverse backgrounds, as well as frequent interactions with clinicians, is essential for making new discoveries and translating them into tomorrow's medicines.
Alzheimer's Disease is one of the most common diseases in the United States. While many existing drugs may help slow the progression of the disease, none can stop it or reverse the damage that it has already done. Several novel immunotherapies are proving efficacious in the treatment of Alzheimer’s Disease, and in particular one drug meant to target cancer may be a promising therapy for Alzheimer’s patients in the future.
The number of children with food allergies is rapidly rising. Simply treating allergic reactions is no longer the best solution for treating these allergies. Researchers are exploring options that may prevent allergies from developing in the first place.
Imagine for a moment that you’re an oncologist, a doctor specializing in cancer diagnosis and treatment. You’re assigned ten patients: five with lung cancer and five with pancreatic cancer. Now, I want you to group these patients into two categories for treatment.